|
|
Volumn 40, Issue 2, 2002, Pages 311-317
|
|
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients
a,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
ENZYME INHIBITION;
ETHNIC DIFFERENCE;
FEMALE;
HEART FAILURE;
HEART LEFT VENTRICLE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SYSTOLIC BLOOD PRESSURE;
TREATMENT PLANNING;
AFRICAN AMERICANS;
AFRICAN CONTINENTAL ANCESTRY GROUP;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BELGIUM;
CANADA;
DOUBLE-BLIND METHOD;
ENALAPRIL;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
RISK;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
VENTRICULAR DYSFUNCTION, LEFT;
|
|
EID: 0037125439
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(02)01943-5 Document Type: Article |
|
Times cited : (84)
|
|
References (20)
|
